Involvement of ERK, p38 MAP kinase, and PKC in MHC class II-mediated signal transduction in a resting B cell line

被引:7
|
作者
Kim, J
Kim, HR
Lee, JC
Jang, YS [1 ]
机构
[1] Chonnam Natl Univ, Div Biol Sci, Chonju 561756, South Korea
[2] Chonnam Natl Univ, Inst Mol Biol & Genet, Chonju 561756, South Korea
关键词
B lymphocyte; major histocompatibility complex; signal transduction;
D O I
10.1006/bbrc.2002.6404
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substantial evidence suggests that MHC class II molecules play a critical role in transducing signals during B cell activation and differentiation. In addition, we previously found that cross-linking of MHC class II molecules using anti-MHC class 11 antibodies inhibited NF-kappaB activation in resting B cells isolated from mouse spleen. In this study, we investigated the mechanism of anti-MHC class 11 antibody-mediated inhibition of LPS-induced NF-kappaB activation using a resting B cell line, 38B9. We found that treatment with a corresponding anti-MHC class II antibody reduced the activation of NF-kappaB in LPS-stimulated 38139 cells, treatment of the antibody mediated down-regulation of PKC and ERK/p38 MAP kinase pathways, and treatment with PKC inhibitors caused down-regulation of ERK and p38 MAP kinase activities in LPS-stimulated 38139 cells. Our results suggest that the PKC and ERK/ p38 MAP kinase pathways are regulated by anti-MHC class II antibodies, and that MHC class II molecules are actively involved in the signal transduction pathway in the resting B cell line, 38B9. Consequently, disruption of these pathways might contribute to the inhibition of LPS-induced NF-kappaB activation in 38B9 cells. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [31] Effects of p38 MAP kinase inhibitors on MDA-MB-231 cell line
    Duzgun, S. A.
    Yerlikaya, A.
    Zeren, S.
    Bayhan, Z.
    Okur, E.
    FEBS JOURNAL, 2016, 283 : 186 - 186
  • [32] Involvement of protein kinase C, p38 MAP kinase and ERK in arachidonic acid-stimulated superoxide production in human neutrophils
    Hii, CST
    Huang, ZH
    Bilney, A
    Stacey, K
    Murray, AW
    Rathjen, DA
    Ferrante, A
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, IMFLAMMATION AND RADIATION INJURY, 4, 1999, 469 : 365 - 370
  • [33] Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway
    Ayala, JM
    Goyal, S
    Liverton, NJ
    Claremon, DA
    O'Keefe, SJ
    Hanlon, WA
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (06) : 869 - 875
  • [34] Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2
    Hazan-Halevy, I
    Levy, T
    Wolak, T
    Lubarsky, I
    Levy, R
    Paran, E
    JOURNAL OF HYPERTENSION, 2005, 23 (06) : 1183 - 1190
  • [35] Negative regulation of MEK/ERK activity and cell proliferation by P38 MAP kinase in the human pancreatic cancer cell line, PANC-1.
    Adrian, TE
    Ding, XZ
    FASEB JOURNAL, 2001, 15 (05): : A1163 - A1163
  • [36] p38 MAP kinase attenuates phorbol ester-mediated activation of the ERK MAP kinase cascade in adult rat ventricular myocytes.
    Chevalier, D
    Allen, BG
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A294 - A294
  • [37] Involvement of CSBP/P38 kinase in signal transduction by hemopoietic growth factors and effects of natural and artificial inhibitors.
    Foltz, I
    Schrader, JW
    BLOOD, 1995, 86 (10) : 2759 - 2759
  • [38] A dual function for p38 map kinase in hematopoietic cells; Involvement in apoptosis and cell activation.
    Birkenkamp, KU
    Dokter, WHA
    Esselink, MT
    Jonk, LJC
    Kruijer, W
    Vellenga, E
    BLOOD, 1997, 90 (10) : 1406 - 1406
  • [39] Involvement of p38 MAP kinase in ET-1 mediated apoptosis of retinal ganglion cells.
    Rao, V
    Krishnamoorthy, R
    Dibas, A
    Yorio, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U182 - U182
  • [40] ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide
    Ogura, Hirotsugu
    Tsukumo, Yoshinori
    Sugimoto, Hikaru
    Igarashi, Masayuki
    Nagai, Kazuo
    Kataoka, Takao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (06) : 922 - 926